Publications

5674 Results

Phase II trial of oral alretamine for women with stage III epithelial ovarian cancer in clinical complete remission: a Southwest Oncology Group study (S9326)

Authors
ML Rothenberg;PY Liu;SA Weiner;V Hunter;A Tiersten;PC Kohler;EV Hannigan;S Wilczynski;DS Alberts
Journal / Conference
Gynecologic Oncology 76(2):263-264(#126)
Year
2000
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-9326

Twenty-four-color spectral karyotyping reveals chromosome aberrations in cytogenetically normal acute myeloid leukemia

Authors
FF Zhang;JL Murata-Collins;P Gaytan;SJ Forman;KJ Kopecky;CL Willman;FR Appelbaum;ML Slovak
Journal / Conference
Genes Chromosomes & Cancer 28:318-328
Year
2000
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9031

Glutathione S-transferase theta 1 gene deletion and risk of acute myeloid leukemia

Authors
C Crump;C Chen;FR Appel baum;KJ Kopecky;SM Schwartz;CL Willman;ML Slovak;NS Weiss
Journal / Conference
Cancer Epidemiology Biomarkers & Prevention 9:457-460
Year
2000
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8600, SWOG-8706, SWOG-9031, SWOG-9034 (EST-3489) (CALGB-9120), SWOG-9129 (INT-0129)

Acute myelogenous leukemia and aging. Clinical interactions.

Authors
JE Lancet;CL Willman;JM Bennett
Journal / Conference
Hematology/Oncology Clinics of North America 14(1):251-267
Year
2000
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8600, SWOG-9031, SWOG-9333

Microsatellite Instability is not a defining genetic feature of acute myeloid leukemogenesis in adults: results of a retrospective study of 132 patients and review of the literature

Authors
LM Rimsza;KJ Kopecky;J Ruschulte;I-M Chen;ML Slovak;C Karanes;J Godwin;A List;CL Willman
Journal / Conference
Leukemia 14:1044-1051
Year
2000
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8326/27, SWOG-9031, SWOG-9126

Cell cycle regulatory gene abnormalities are important determinants of leukemogenesis and disease biology in adult a2000 Apr 1;95(7):2364-71.cute lymphoblastic leukemia

Authors
W Stock;T Tsai;C Golden;C Rankin;D Sher;ML Slovak;MG Pallavicini;JP Radich;DH Boldt
Journal / Conference
Blood Apr 1;95(7):2364-71
Year
2000
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8417/19, SWOG-9400

Molecular analysis and clinical outcome of adult APL patients with the type V PML-RARa isoform: results from Intergroup protocol 0129

Authors
JL Slack;CL WIllman;JW Andersen;YP Li;DS Viswanatha;CD Bloomfield;MS Tallman;RE Gallagher
Journal / Conference
Blood 95(2):398-403
Year
2000
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9129 (INT-0129)

Analysis of MLH1 and MSH2 expression in ovarian cancer before and after platinum drug-based chemotherapy

Authors
G Samimi;D Fink;NM Varki;A Husain;WJ Hoskins;DS Alberts;SB Howell
Journal / Conference
Clinical Cancer Research 6:1415-1421
Year
2000
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8835

Effects of leucovorin (LV) on the intratumoral (IT) pharmacokinetics (PK) of 5-fluorouracil (5-FU) - a Southwest Oncology Group study

Authors
W Wolf;CA Presant;V Waluch;I Weitz;J Jacobson
Journal / Conference
Proc of the American Association for Cancer Research 41:611(#3885)
Year
2000
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9006

Spectroscopic evaluation of intratumoral (IT) metabolic modulation (MM) of 5-fluorouracil (5-FU) by leucovorin (LV): Correlation of human tumor pharmacokinetics (PK) with modulation and tumore response. SWOG 9006

Authors
CA Presant;W Wolf;V Waluch;I Weitz;J Jacobson
Journal / Conference
Proc of the American Society of Clinical Oncology 19:194a(#754)
Year
2000
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9006